1/30/2022 | 3002150000 | MEDICINES (MODIFIED IMMUNOLOGICAL PRODUCTS) INTENDED FOR CLINICAL STUDIES ACCORDING TO PROTOCOL BO40729, NOT ETHYL ALCOHOL, NOT FOR THERAPEUTIC USE, NOT FOR VETERINARY, NOT FOR SALE, (PACK B | 1.09 | 138987.2 | Ireland | SHEREMETIEVO 2 MOSCOW RUSSIA | REPRESENTATIVE OFFICE OF THE LLC F HOFFMANN LA ROCH LIMITED |
1/19/2022 | 3004900008 | UNREGISTERED MEDICINES FOR USE FOR THERAPEUTIC PURPOSES, PACKED IN THE FORMS OF DOSED DOSAGE FORMS, ARE INTENDED TO PROVIDE MEDICAL CARE FOR VITAL INDICATIONS TO PATIENTS | 0.5 | 68847.1 | Ireland | GERMANY MERZIG | MEDINTORG JSC |
1/19/2022 | 3004900008 | UNREGISTERED MEDICINES FOR USE FOR THERAPEUTIC PURPOSES, PACKED IN THE FORMS OF DOSED DOSAGE FORMS, ARE INTENDED TO PROVIDE MEDICAL CARE FOR VITAL INDICATIONS TO PATIENTS | 1.2 | 183695.1 | Ireland | GERMANY MERZIG | MEDINTORG JSC |
1/27/2022 | 3002150000 | MEDICINES (MODIFIED IMMUNOLOGICAL PRODUCTS) INTENDED FOR CLINICAL STUDIES ACCORDING TO PROTOCOL BO40729, NOT ETHYL ALCOHOL, NOT FOR THERAPEUTIC USE, NOT FOR VETERINARY, NOT FOR SALE, (PACK B | 9.3 | 22973 | Ireland | SHEREMETIEVO 2 MOSCOW RUSSIA | REPRESENTATIVE OFFICE OF THE LLC F HOFFMANN LA ROCH LIMITED |